Chlamydia pneumoniae and cytomegalovirus seropositivity, inflammatory markers, and the risk of myocardial infarction at a young age

被引:51
作者
Gattone, M
Iacoviello, L
Colombo, M
Di Castelnuovo, A
Soffiantino, F
Gramoni, A
Picco, D
Benedetta, M
Giannuzzi, P
机构
[1] Med Ctr Rehabil, Salvatore Maugeri Fdn, Inst Clin Care & Res, Ist Ric & Cura Carettere Sci,Dept Cardiol, I-28010 Verano, NO, Italy
[2] Med Ctr Rehabil, Salvatore Maugeri Fdn, Inst Clin Care & Res, Ist Ric & Cura Carettere Sci,Lab Unit, Verano, NO, Italy
[3] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Vasc Med & Pharmacol, Angela Valenti Lab Genet & Environm Risk Factors, I-66030 Santa Maria Imbaro, Italy
关键词
D O I
10.1067/mhj.2001.118118
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Pathogens causing chronic infections may promote atherosclerosis. The aim of our study was to evaluate the association of Chlamydia pneumoniae (Cp) and cytomegalovirus (CMV) infection and of inflammatory activation with premature myocardial infarction (MI). Methods Specific anti-Cp and anti-CMV immunoglobulin G (IgG), fibrinogen, white blood cells (WBC), and C-reactive protein (CRP) were measured in 120 post-Ml patients less than or equal to 50 years old and in 120 age-matched controls. Results Seropositivity to Cp and elevated concentrations of anti-Cp and anti-CMV IgGs were more frequent (P = .01) in patients than in control subjects, and fibrinogen, CRP, and WBC levels (P = .02) were more elevated. After adjustment for coronary risk factors and socioeconomic status, the odds ratios (95% confidence intervals) for premature MI were 2.4 (1.3-4.6) for Cp infection and 2.9 (1.5-5.8) for CMV. The risk of Cp infection was greater in smokers (3.7, 1.8-7.6). When both infections were present (35% of patients vs 8% of controls, P = .001), CRP was higher (P = .01) and the risk increased by 12 times (12.5, 4-38.9) compared with that in subjects without any infection and by 5 times (4.9, 2.2-10.9) if only one was present. Conclusions After adjustment for confounders, seropositivity to both Cp and CMV infections is associated with the diagnosis of premature MI. The combination of both infections is associated with an enhanced inflammatory response and a markedly increased risk of premature MI.
引用
收藏
页码:633 / 640
页数:8
相关论文
共 35 条
[1]  
ADAM E, 1987, LANCET, V2, P291
[2]   Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction [J].
Anderson, JL ;
Carlquist, JF ;
Muhlestein, JB ;
Horne, BD ;
Elmer, SP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (01) :35-41
[3]   Chronic infection with Helicobacter pylori, Chlamydia pneumoniae, or cytomegalovirus:: population based study of coronary heart disease [J].
Danesh, J ;
Wong, Y ;
Ward, M ;
Muir, J .
HEART, 1999, 81 (03) :245-247
[4]   Chronic infections and coronary heart disease: is there a link? [J].
Danesh, J ;
Collins, R ;
Peto, R .
LANCET, 1997, 350 (9075) :430-436
[5]   Helicobacter pylori infection and early onset myocardial infarction:: case-control and sibling pairs study [J].
Danesh, J ;
Youngman, L ;
Clark, S ;
Parish, S ;
Peto, R ;
Collins, R .
BRITISH MEDICAL JOURNAL, 1999, 319 (7218) :1157-1162
[6]   Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease - Meta-analyses of prospective studies [J].
Danesh, J ;
Collins, R ;
Appleby, P ;
Peto, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18) :1477-1482
[7]   Lack of association of infectious agents with risk of future myocardial infarction and stroke - Definitive evidence disproving the infection/coronary artery disease hypothesis? [J].
Epstein, SE ;
Zhu, JH .
CIRCULATION, 1999, 100 (13) :1366-1368
[8]   LIPOPROTEIN CHOLESTEROL, APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-B AND LIPOPROTEIN-(A) ABNORMALITIES IN MEN WITH PREMATURE CORONARY-ARTERY DISEASE [J].
GENEST, J ;
MCNAMARA, JR ;
ORDOVAS, JM ;
JENNER, JL ;
SILBERMAN, SR ;
ANDERSON, KM ;
WILSON, PWF ;
SALEM, DN ;
SCHAEFER, EJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (04) :792-802
[9]   Antibiotic treatment trials for secondary prevention of coronary artery disease events [J].
Grayston, JT .
CIRCULATION, 1999, 99 (12) :1538-1539
[10]   SERUM-LIPOPROTEINS AND APOLIPOPROTEINS IN YOUNG MALE SURVIVORS OF MYOCARDIAL-INFARCTION [J].
HAMSTEN, A ;
WALLDIUS, G ;
DAHLEN, G ;
JOHANSSON, B ;
DEFAIRE, U .
ATHEROSCLEROSIS, 1986, 59 (02) :223-235